1-4 of 4
Tina Nuebling, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Elimination Of Minimal Residual Disease (MRD) In AML Patients With a Novel Fc-Optimized FLT3 Antibody (4G8-SDIEM)

Helmut R. Salih, MD, Martin Hofmann, Ludger Grosse-Hovest, PhD, Tina Nuebling, PhD, Maximilian Bamberg, Steffen Aulwurm, PhD, Hans-Joerg Buehring, PHD, Wolfgang A. Bethge, MD, Lothar Kanz, MD, Gundram Jung, MD
Journal: Blood
Blood (2013) 122 (21): 1454.
https://doi.org/10.1182/blood.V122.21.1454.1454
Published: 2013
Journal Articles

Induction of NK Cell Reactivity Against AML Cells by Fc-Engineered RANK-Ig Fusion Proteins.

Tina Nuebling, PhD, Benjamin J Schmiedel, PhD, Miyuki Azuma, MD, PhD, Pascal Schneider, PhD, Ludger Grosse-Hovest, PhD, Lothar Kanz, MD, Helmut R Salih, MD
Journal: Blood
Blood (2012) 120 (21): 2625.
https://doi.org/10.1182/blood.V120.21.2625.2625
Published: 2012
Journal Articles

The Role of OX40 and Its Ligand in Acute Myeloid Leukemia: Expression, Function and Modulation of NK Cell Anti-Leukemia Reactivity

Carla E Schumacher, Tina Nuebling, PhD, Martin Hofmann, Benjamin J Schmiedel, PhD, Lothar Kanz, MD, Gundram Jung, MD, Helmut R Salih, MD
Journal: Blood
Blood (2012) 120 (21): 3548.
https://doi.org/10.1182/blood.V120.21.3548.3548
Published: 2012
Journal Articles

Bimodal Induction of NK Cell Reactivity Against Acute Myeloid (AML) and Chronic Lymphoid Leukemia (CLL) by Fc-Engineered GITR-Fc Fusion Proteins.

Julia Steinbacher, Benjamin J Schmiedel, PhD, Antje Werner, Tina Nuebling, PhD, Corina Buechele, Ludger Grosse-Hovest, PhD, Lothar Kanz, MD, Helmut R Salih, MD
Journal: Blood
Blood (2012) 120 (21): 2143.
https://doi.org/10.1182/blood.V120.21.2143.2143
Published: 2012